FDA Clearance Tracker · P140008-S028
ORBERA INTRAGASTRIC BALLOON
Last checked: Nov 20, 2026Latest source record: Jan 5, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jan 5, 2026
Approved
Time to decision
46 days
Received Nov 20, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P140008-S028
- Device name
- ORBERA INTRAGASTRIC BALLOON
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marlboro, MA
- Received
- Nov 20, 2025
- Decided
- Jan 5, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P140008
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
a manufacturing site change to replace the Apollo Endosurgery Coyol, Costa Rica facility with the Boston Scientific Coyol, Costa Rica facility for the Orbera Intragastric Balloon, following acquisition of Apollo Endosurgery by Boston Scientific
Source documents
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.